Lisa Trivison Beck
Corporate Officer/Principal en BRII BIOSCIENCES LIMITED .
Perfil
Lisa Trivison Beck is currently the Senior Vice President-Business Development at Brii Biosciences Ltd.
(China) since 2019.
Prior to this, she worked at Alexion Pharmaceuticals, Inc. as the Head-Transactions & Alliance Management from 2015 to 2018.
She also worked at GSK Plc for 24 years from 1991 to 2015, where she held the position of Director-Portfolio Management.
Ms. Beck completed her undergraduate degree from Vanderbilt University in 1984.
Cargos activos de Lisa Trivison Beck
| Empresas | Cargo | Inicio |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Corporate Officer/Principal | 17/12/2019 |
Antiguos cargos conocidos de Lisa Trivison Beck.
| Empresas | Cargo | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2018 |
| GSK PLC | Corporate Officer/Principal | 01/08/2015 |
Formación de Lisa Trivison Beck.
| Vanderbilt University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRII BIOSCIENCES LIMITED | Commercial Services |
| GSK PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Lisa Trivison Beck
